Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile
Year: 2001
Type: article
Source: European Journal of Pharmacology
Institution: Pfizer (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: ziprasidone, antipsychotic drugs, serotonin receptors, dopamine D2 receptor, 5-HT1A receptor agonism, 5-HT2A receptor antagonism, 5-HT2C receptor antagonism, serotonin uptake inhibition, norepinephrine reuptake inhibition, schizophrenia, extrapyramidal symptoms, cognitive impairment, weight gain
Open Access status: closed
Funder: Pfizer
OpenAlex ID: W1973799461
